So, Should You Go With a GHK-Cu Topical or Injection
For a comprehensive understanding of all potential side effects, consult a medical professional
Documented symptomatic hypoglycemia (glucose of 70 mg/dL or less) was reported in 16.7% to 29.8% of patients receiving semaglutide, and severe or blood glucose confirmed symptomatic hypoglycemia (glucose of 56 mg/dL or less) was reported in 8.3% to 10.7% of patients receiving semaglutide
In contrast, AHK-Cu is once daily
Improved Energy: Vitamin B12 can improve or boost energy levels
Medical Weight Loss Semaglutide, Tirzepatide, lipotropic injections, B12 therapy, and metabolic support